The Translational Research Institute (TRI), a company based in Gilbert, Arizona, received FDA approval for its Nabil Dib (ND) Infusion Catheter for delivering therapeutic fluids into coronary vasculature. The device features an inflatable balloon that can occlude a variety of arteries up to 4.5 mm in diameter. The catheter regulates the flow of the delivered fluid to maintain a safe pressure, while multiple channels at the distal end of the device help make sure the liquid is distributed well throughout the vessel lumen.
Help employers find you! Check out all the jobs and post your resume.
